Sensus Healthcare, Inc. carries a market capitalization of 46.75M, placing it among publicly traded companies globally. Its enterprise value stands at 47.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 46.75M |
| Enterprise Value | 47.18M |
Sensus Healthcare, Inc. currently has 16.46M shares outstanding.
| Shares Outstanding | 16.46M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 2.89, and the price-to-book ratio stands at 19.98.
| PE Ratio | N/A |
| PS Ratio | 2.89 |
| PB Ratio | 19.98 |
| P/TBV Ratio | 1.43 |
| P/FCF Ratio | -182.87 |
| P/OCF Ratio | -118.80 |
| EV / Sales | 2.09 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 91.41 |
Sensus Healthcare, Inc. maintains a current ratio of 7.27, meaning it holds 7.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.27 |
| Quick Ratio | 3.74 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | -0.04 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | -108.80 |
| Return on Assets (ROA) | -13.91 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.06 |
| Income Tax | -3.62M |
| Effective Tax Rate | N/A |
Sensus Healthcare, Inc.'s stock has declined approximately -41.92229% over the past 52 weeks. The 50-day moving average sits at 3.84, while the 200-day moving average is 3.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.92229% |
| 50-Day Moving Average | 3.84 |
| 200-Day Moving Average | 3.87 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Sensus Healthcare, Inc. generated 22.53M in revenue and converted that into -7.77M in net income, yielding earnings per share of -0.48. EBITDA reached -11.38M, while operating income came in at -12.02M.
| Revenue | 22.53M |
| Gross Profit | 8.50M |
| Operating Income | -12.02M |
| Pretax Income | -11.39M |
| Net Income | -7.77M |
| EBITDA | -11.38M |
| EBIT | -12.02M |
| Earnings Per Share (EPS) | -0.48 |
Sensus Healthcare, Inc. holds 18.33M in cash and equivalents against 408,000.00 in total debt, resulting in a net debt position of -18.33M. Total book value stands at 3.26M, with working capital of 36.73M providing operational flexibility.
| Cash & Cash Equivalents | 18.33M |
| Total Debt | 408,000.00 |
| Net Debt | -18.33M |
| Equity (Book Value) | 3.26M |
| Book Value Per Share | 0.20 |
| Working Capital | 36.73M |
Sensus Healthcare, Inc. produced -548,000.00 in operating cash flow over the past twelve months. After subtracting -192,000.00 in capital expenditures, free cash flow totaled -740,000.00 - equivalent to -0.05 per share.
| Operating Cash Flow | -548,000.00 |
| Capital Expenditures | -192,000.00 |
| Free Cash Flow | -740,000.00 |
| FCF Per Share | -0.05 |
Sensus Healthcare, Inc. operates with a gross margin of 37.74, reflecting its pricing power and cost economics. The operating margin of -53.34 and net profit margin of -34.50 provide insight into operational efficiency.
| Gross Margin | 37.74 |
| Operating Margin | -53.34 |
| Pretax Margin | -50.57 |
| Profit Margin | -34.50 |
| EBITDA Margin | -50.50 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.01 |
| FCF Yield | -0.55 |
Sensus Healthcare, Inc. posts an Altman Z-Score of 7.11, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.11 |